Genetic traits for hematogeneous tumor cell dissemination in cancer patients.
about
Challenges and unanswered questions for the next decade of circulating tumour cell research in lung cancer.Circulating Tumor Cells (CTC) and Cell-Free DNA (cfDNA) Workshop 2016: Scientific Opportunities and Logistics for Cancer Clinical Trial Incorporation.Sensitive detection of PD-L1 expression on circulating epithelial tumor cells (CETCs) could be a potential biomarker to select patients for treatment with PD-1/PD-L1 inhibitors in early and metastatic solid tumors.Evaluation of incidence, significance, and prognostic role of circulating tumor microemboli and transforming growth factor-β receptor I in head and neck cancer.Techniques of using circulating tumor DNA as a liquid biopsy component in cancer management
P2860
Genetic traits for hematogeneous tumor cell dissemination in cancer patients.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Genetic traits for hematogeneous tumor cell dissemination in cancer patients.
@en
type
label
Genetic traits for hematogeneous tumor cell dissemination in cancer patients.
@en
prefLabel
Genetic traits for hematogeneous tumor cell dissemination in cancer patients.
@en
P2860
P1476
Genetic traits for hematogeneous tumor cell dissemination in cancer patients.
@en
P2093
Klaus Pantel
Simon A Joosse
P2860
P2888
P356
10.1007/S10555-016-9611-7
P577
2016-03-02T00:00:00Z
P6179
1029007694